Medications
EU approves Novartis-Incyte blood cancer drug
Novartis AG and Incyte Corp. said Tuesday that European Union regulators approved their blood cancer drug Jakavi.
Sep 4, 2012
0
0
Novartis AG and Incyte Corp. said Tuesday that European Union regulators approved their blood cancer drug Jakavi.
Sep 4, 2012
0
0
A multiple sclerosis drug made by industry giant Novartis is under investigation after at least 11 patients taking the medicine died.
Jan 20, 2012
0
0